Author： Mihich E. Ehrke M.J.
Publisher： Elsevier
ISSN： 0192-0561
Source： International Journal of Immunopharmacology, Vol.22, Iss.12, 2000-12, pp. : 1077-1081
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies
By Bankert R.B. Egilmez N.K. Hess S.D.
Trends in Immunology, Vol. 22, Iss. 7, 2001-07 ,pp. :
Access to resources
Recommend
Cytokines and infections: good, bad and effective therapies?
By Balkwill F.
Trends in Immunology, Vol. 23, Iss. 7, 2002-07 ,pp. :
Pancreatic Neuroendocrine Tumors: Signal Pathways and Targeted Therapies
Current Molecular Medicine, Vol. 13, Iss. 3, 2013-01 ,pp. :
Receptor tyrosine kinases as targets for anticancer drugs
By Zwick E. Bange J. Ullrich A.
Trends in Molecular Medicine, Vol. 8, Iss. 1, 2002-01 ,pp. :